Daniel Clark
Stock Analyst at Leerink Partners
(2.40)
# 2,518
Out of 5,245 analysts
8
Total ratings
66.67%
Success rate
11.86%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELAN Elanco Animal Health | Maintains: Outperform | $26 → $30 | $21.73 | +38.06% | 3 | Feb 24, 2026 | |
| IDXX IDEXX Laboratories | Maintains: Outperform | $580 → $600 | $559.37 | +7.26% | 3 | Jul 17, 2025 | |
| ZTS Zoetis | Downgrades: Market Perform | $180 → $155 | $81.32 | +90.61% | 2 | Jul 17, 2025 |
Elanco Animal Health
Feb 24, 2026
Maintains: Outperform
Price Target: $26 → $30
Current: $21.73
Upside: +38.06%
IDEXX Laboratories
Jul 17, 2025
Maintains: Outperform
Price Target: $580 → $600
Current: $559.37
Upside: +7.26%
Zoetis
Jul 17, 2025
Downgrades: Market Perform
Price Target: $180 → $155
Current: $81.32
Upside: +90.61%